News About: Med. Insurance
Cost-effectiveness of Lipitor 10mg should be re-evaluated
Makers of fiver statin preparations have urged the Heath Insurance Review and Assessment Service (HIRA) to conduct the economic analysis of Lipitor 10mg once again.
On November 12, the HIRA announced a new economic...
Incentive drugs for substitute dispensing top 3,923
A total of 3,923 incentive drugs, which have been endorsed by bioequivalence tests, are available for substitute dispensing as of October 2008, up 213 items compared to 3710 in July, according to data released by the ...
Health providers back deregulation of health insurance polices
The current health insurance system isn't set in place mainly due to biased medical security system, said the nation’s health providers.
A statement, which was issued on November 11 by the nation’s five health prov...
HIRA to evaluate economic effectiveness of antihypertensive drugs next year
The Health Insurance Review and Assessment Service (HIRA) plans to evaluate the economic effectiveness of antihypertensive agents and other medicines between 2009 and 2013 and gradually readjust prices and exclude ite...
Health insurance to cover MSD’s Januvia tablets
The National Health Insurance Corporation said on November 11 that it finally agreed with MSD Korea to get Januvia (sitagliptin phosphate) listed in the national health insurance.
Under the agreement, Januvia 100 m...
Health insurance to cover Lyrica in fibromyalgia patients
The Ministry of Health, Welfare and Family Affairs announced on November 6 that the national health insurance has covered from November Lyrica (pregabalin) in patients with fibromyalgia, a disorder characterized by pa...
Civic groups calls for rapid re-negotiation of Glivec price
Activists are re-directing most of their rage at Novartis.
The coalition for the Right to Access Glivec in Korea and the Korea Federation of Activist Fighting for Health Rights said that the National Health Insuran...
Health insurance allowance possible over obesity on limited basis
The government will increase health insurance benefits for treatment of “severe obesity” requiring surgery only, the Ministry of Health, Welfare and Family Affairs announced on October 27.
In a telephone conversati...
Civic groups denounce delayed price cut of lipid-lowering agents
The nation’s 10 civic groups have criticized the government’s delayed determination over the proposed price cut of lipid-lowering medicines.
The Health Right Network said on October 23 that the Health Insurance Rev...
Price cut of antihyperlipemic agents likely to be determined early November
Will the assessment of the conventional antihyperlipemic drugs be made available soon? Now all eyes are on the Health Insurance Review and Assessment Service committee’s decision on the scope of their price reduction....
